Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 67, Issue 9, 2012, Pages 1190-1191

  Alvarez Twose, I ^a,b   Matito, A ^a,b   Sanchez Munoz L ^a,b   Morgado, J M ^a,b   Orfao, A ^b,c   Escribano, L ^a,b  

^a HOSPITAL VIRGEN DE LA SALUD   (Spain)

^b Red Española de Mastocitosis REMA   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE DERIVATIVE; TRYPTASE;

ANAPHYLAXIS; DIAGNOSTIC VALUE; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; HUMAN; LETTER; PRIORITY JOURNAL; SEX DIFFERENCE; SKIN DEFECT; SYMPTOM; SYSTEMIC MASTOCYTOSIS;

FEMALE; HUMANS; IMIDAZOLES; MALE; MASTOCYTOSIS, SYSTEMIC; METHYLHISTAMINES; TRYPTASES; URTICARIA PIGMENTOSA;

EID: 84865026377     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2012.02850.x     Document Type: Letter

References (6)

1. Van Doormaal JJ, van der Veer E, van Voorst Vader PC, Kluin PM, Mulder AB, van der Heide S, et al. Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions. Allergy 2012; 67: 683-690.
2. Alvarez-Twose I, Gonzalez deOlano D, Sanchez-Munoz L, Matito A, Esteban-Lopez MI, Vega A, et al. Clinical, biological and molecular characteristics of systemic mast cell disorders presenting with severe mediator-related symptoms. J Allergy Clin Immunol 2010; 125: 1269-1278.
3. Alvarez-Twose I, Gonzalez-de-Olano D, Sanchez-Munoz L, Matito A, Jara-Acevedo M, Teodosio C, et al. Validation of the REMA Score for Predicting Mast Cell Clonality and Systemic Mastocytosis in Patients with Systemic Mast Cell Activation Symptoms. Int Arch Allergy Immunol 2011; 157: 275-280.
4. Garcia-Montero AC, Jara-Acevedo M, Teodosio C, Sanchez ML, Nunez R, Prados A, et al. KIT mutation in mast cells and other bone marrow haematopoietic cell lineages in systemic mast cell disorders. A prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients. Blood 2006; 108: 2366-2372.
5. Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal FD, et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 2009; 123: 680-686.
6. Valent P, Akin C, Arock M, Brockow K, Butterfield JH, Carter MC, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol 2011; 157: 215-225.